We are live on ! Find out more
SIP

Stoneridge Investment Partners Portfolio holdings

AUM $152M
1-Year Est. Return 20.58%
This Fund
S&P 500
This Quarter Est. Return
-0.06%
1 Year Est. Return
+20.58%
3 Year Est. Return
+44.17%
5 Year Est. Return
+32.14%
10 Year Est. Return
+92.72%
AUM
$144M
AUM Growth
-$2.12M
Cap. Flow
-$1.1M
Cap. Flow %
-0.76%
Top 10 Hldgs %
40.41%
Holding
167
New
45
Increased
41
Reduced
36
Closed
41

Top Buys

Rank Stock Value
1
NKE icon
Nike
NKE
+$4.76M
2
WRB icon
W.R. Berkley
WRB
+$2.94M
3
ZTS icon
Zoetis
ZTS
+$2.84M
4
AMZN icon
Amazon
AMZN
+$2.48M
5
ZBH icon
Zimmer Biomet
ZBH
+$2.14M

Top Sells

Rank Stock Value
1
CB icon
Chubb
CB
+$4.1M
2
WFC icon
Wells Fargo
WFC
+$3.94M
3
TJX icon
TJX Companies
TJX
+$3.69M
4
BAX icon
Baxter International
BAX
+$2.13M
5
MRK icon
Merck
MRK
+$2M

Sector Composition

Rank Sector Weight
1 Technology 37.36%
2 Consumer Discretionary 12.71%
3 Financials 10.19%
4 Communication Services 9.71%
5 Healthcare 8.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DFTX
151
Definium Therapeutics
DFTX
$5.45B
-11,563
Closed -$136K
MRK icon
152
Merck
MRK
$321B
-23,773
Closed -$2M
NVRI icon
153
Enviri
NVRI
$604M
-12,440
Closed -$158K
PEG icon
154
Public Service Enterprise Group
PEG
$37.3B
-21,634
Closed -$1.81M
RAMP icon
155
LiveRamp
RAMP
$2.3B
-9,622
Closed -$261K
REGN icon
156
Regeneron Pharmaceuticals
REGN
$83.1B
-2,360
Closed -$1.33M
SPY icon
157
State Street SPDR S&P 500 ETF Trust
SPY
$809B
-2,883
Closed -$1.92M
TERN
158
DELISTED
Terns Pharmaceuticals
TERN
-16,867
Closed -$127K
TXN icon
159
Texas Instruments
TXN
$258B
-9,643
Closed -$1.77M
UAMY icon
160
United States Antimony
UAMY
$969M
-22,037
Closed -$137K
UCTT
161
Ultra Clean Holdings
UCTT
$3.79B
-7,994
Closed -$218K
VICR icon
162
Vicor
VICR
$9.78B
-6,498
Closed -$323K
WAB icon
163
Wabtec
WAB
$50.2B
-2,058
Closed -$413K
WFC icon
164
Wells Fargo
WFC
$265B
-47,030
Closed -$3.94M
GUTS icon
165
Fractyl Health
GUTS
$107M
-23,721
Closed -$38K
ALMS
166
Alumis Inc
ALMS
$3.13B
-29,535
Closed -$118K
RZLV
167
Rezolve AI
RZLV
$1.09B
-11,607
Closed -$58K

Similar funds

Stoneridge Investment Partners's Q4 2025 Portfolio in Review

As of Q4 2025, Stoneridge Investment Partners held 167 positions worth $144M, down 1.5% from $146M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Stoneridge Investment Partners's Q4 2025 filing shows 45 new, 41 increased, 36 reduced and 41 closed positions. Its largest new stake was W.R. Berkley: 39,946 shares worth $2.8M. The largest sale was Chubb, an estimated $4.1M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 36% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Stoneridge Investment Partners's largest Q4 2025 buy was W.R. Berkley: 39,946 shares worth $2.8M.
  • Stoneridge Investment Partners added most to Nike in Q4 2025, an estimated $4.76M increase.
  • Stoneridge Investment Partners's biggest Q4 2025 reduction was TJX Companies, cutting an estimated $3.69M.
  • Stoneridge Investment Partners fully exited Chubb in Q4 2025, selling an estimated $4.1M.
  • Stoneridge Investment Partners's ten largest holdings make up 40% of its $144M portfolio in Q4 2025.
  • Stoneridge Investment Partners opened 45 new positions and closed 41 in Q4 2025.
  • Stoneridge Investment Partners's portfolio value fell 1.5% quarter-over-quarter to $144M.

Based on Stoneridge Investment Partners's 13F filing for Q4 2025, filed 5 Feb 2026.